BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 100,189,285
- Share change
- -396,930
- Total reported value
- $379,651,222
- Put/Call ratio
- 98%
- Price per share
- $3.79
- Number of holders
- 112
- Value change
- -$87,862,478
- Number of buys
- 60
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
7.2%
|
15,118,081
|
$123,061,000 | — | 31 Mar 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
5.8%
|
12,257,442
|
$99,776,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
8,697,366
|
$70,796,000 | — | 31 Mar 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.1%
|
8,659,983
|
$70,492,000 | — | 31 Mar 2019 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.1%
|
6,537,566
|
$53,216,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
6,043,507
|
$49,194,000 | — | 31 Mar 2019 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.8%
|
5,955,762
|
$48,480,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
3,510,042
|
$28,572,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
1.6%
|
3,467,998
|
$28,229,000 | — | 31 Mar 2019 | |
| VHCP Management II, LLC |
13F
|
Company |
1.5%
|
3,249,164
|
$26,448,000 | — | 31 Mar 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.5%
|
3,100,864
|
$25,241,000 | — | 31 Mar 2019 | |
| VHCP Management III, LLC |
13F
|
Company |
1.5%
|
3,061,091
|
$24,917,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
2,208,875
|
$17,980,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.74%
|
1,556,785
|
$12,672,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.65%
|
1,360,934
|
$11,078,000 | — | 31 Mar 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.64%
|
1,338,695
|
$10,897,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,324,509
|
$10,781,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.43%
|
902,660
|
$7,348,000 | — | 31 Mar 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.42%
|
882,851
|
$7,186,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
779,365
|
$6,345,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.37%
|
779,406
|
$6,344,000 | — | 31 Mar 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.33%
|
700,000
|
$5,698,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
511,113
|
$4,160,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
510,408
|
$4,155,000 | — | 31 Mar 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.24%
|
500,000
|
$4,070,000 | — | 31 Mar 2019 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
498,415
|
$4,057,000 | — | 31 Mar 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.2%
|
412,876
|
$3,360,811 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
383,614
|
$3,122,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
366,784
|
$2,986,000 | — | 31 Mar 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.16%
|
334,728
|
$2,725,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
318,129
|
$2,589,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.15%
|
317,364
|
$2,583,000 | — | 31 Mar 2019 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.14%
|
287,805
|
$2,343,000 | — | 31 Mar 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
273,608
|
$2,227,000 | — | 31 Mar 2019 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.13%
|
265,013
|
$2,157,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.12%
|
250,182
|
$2,034,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
241,372
|
$1,965,000 | — | 31 Mar 2019 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.11%
|
234,898
|
$1,913,000 | — | 31 Mar 2019 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.11%
|
221,565
|
$1,804,000 | — | 31 Mar 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
193,812
|
$1,578,000 | — | 31 Mar 2019 | |
| Global IMC LLC |
13F
|
Company |
0.09%
|
180,199
|
$1,467,000 | — | 31 Mar 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.08%
|
170,957
|
$1,391,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
168,289
|
$1,370,000 | — | 31 Mar 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
149,535
|
$1,217,000 | — | 31 Mar 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
149,200
|
$1,214,000 | — | 31 Mar 2019 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.07%
|
140,000
|
$1,140,000 | — | 31 Mar 2019 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
139,900
|
$1,139,000 | — | 31 Mar 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.06%
|
129,306
|
$1,053,000 | — | 31 Mar 2019 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.06%
|
125,307
|
$1,020,000 | — | 31 Mar 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
116,320
|
$947,000 | — | 31 Mar 2019 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2019
As of 30 Jun 2019,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,189,285 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CITADEL ADVISORS LLC, FMR LLC, and VHCP Management II, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
129
Q2 2019 holders
112
Holder diff
-17
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.